The integrase from phage f C31 of Streptomyces bacteria is an attractive recombinase for use in generating transgenic organisms and developing gene and cell therapeutic strategies. In nature, f C31 integrase mediates integration by interacting with speci fi c sites in the phage and bacterial genomes. When applied to eukaryotes, f C31 integrase provides ef fi cient unidirectional recombination between its own attB and attP sites or between an attB site on an incoming plasmid and a native genomic pseudo attP site that resembles attP . To date, the f C31 system has been used to generate stable transgenic organisms from multiple species, including plants, insects, and vertebrates. The features of the f C31 system also make it particularly amenable to therapeutic strategies. f C31 integrase has been used in potential therapies for numerous genetic diseases including hemophila, muscular dystrophy, and skin disorders. Additionally, the f C31 system has recently been used to modify human embryonic stem cells and to generate induced pluripotent stem cells. The f C31 system can also be combined with other recombinases to create advanced genome engineering strategies. In the future, the use of f C31 integrase may facilitate the development of new gene and cell therapies, as well as the generation of targeted transgenic organisms.